Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Cash from Investing Activities (2020 - 2025)

Historic Cash from Investing Activities for Sotera Health (SHC) over the last 6 years, with Q3 2025 value amounting to -$33.3 million.

  • Sotera Health's Cash from Investing Activities rose 829.94% to -$33.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$150.3 million, marking a year-over-year increase of 1553.06%. This contributed to the annual value of -$179.0 million for FY2024, which is 1670.96% up from last year.
  • Sotera Health's Cash from Investing Activities amounted to -$33.3 million in Q3 2025, which was up 829.94% from -$31.2 million recorded in Q2 2025.
  • Over the past 5 years, Sotera Health's Cash from Investing Activities peaked at -$16.6 million during Q3 2021, and registered a low of -$72.3 million during Q4 2021.
  • Over the past 5 years, Sotera Health's median Cash from Investing Activities value was -$39.0 million (recorded in 2022), while the average stood at -$43.2 million.
  • The largest annual percentage gain for Sotera Health's Cash from Investing Activities in the last 5 years was 8575.23% (2021), contrasted with its biggest fall of 28491.0% (2021).
  • Sotera Health's Cash from Investing Activities (Quarter) stood at -$72.3 million in 2021, then grew by 0.73% to -$71.7 million in 2022, then grew by 9.64% to -$64.8 million in 2023, then fell by 1.61% to -$65.9 million in 2024, then surged by 49.39% to -$33.3 million in 2025.
  • Its Cash from Investing Activities stands at -$33.3 million for Q3 2025, versus -$31.2 million for Q2 2025 and -$19.9 million for Q1 2025.